drugset

drugset / Trial / NCT04008979

Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex

NCT04008979 ↗

Phase 1 Completed 32 enrolled PLx Pharma

RandomizedCrossoverDouble-blindTreatment

Summary

Prospective, Randomized, Crossover, Bioequivalence study

Timeline

Start: 2008-02-11
Primary completion: 2008-06-10
Completion: 2008-06-10

Publications

Angiolillo DJ, Bhatt DL, Lanza F, Cryer B, Dong JF, Jeske W, Zimmerman RR, von Chong E, Prats J, Deliargyris EN, Marathi U. Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence study. J Thromb Thrombolysis. 2019 Nov;48(4):554-562. doi: 10.1007/s11239-019-01933-7.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aspirin	Small molecule	325 mg	—
Subject	Aspirin	Small molecule	650 mg	—

Indications

No indication recorded.